Safety and Efficacy of Eculizumab Therapy in Multiple Sclerosis: A Case Series

(1) Background: Complement system activation has been proposed as one of the different factors that contribute to Multiple Sclerosis (MS) pathogenesis. In this study, we aimed to describe the potential effects of eculizumab, an anticomplement therapy, on MS disease activity in a cohort of relapsing–...

Descripción completa

Detalles Bibliográficos
Autores principales: Allinovi, Marco, Bellinvia, Angelo, Pesce, Francesco, Milan Manani, Sabrina, Razzolini, Lorenzo, Brezzi, Brigida, Protopapa, Paolo, Mantero, Vittorio, Caroti, Leonardo, Cirami, Calogero Lino, Amato, Maria Pia, Del Vecchio, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533854/
https://www.ncbi.nlm.nih.gov/pubmed/34679405
http://dx.doi.org/10.3390/brainsci11101341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533854/
https://www.ncbi.nlm.nih.gov/pubmed/34679405
http://dx.doi.org/10.3390/brainsci11101341

Ejemplares similares